• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Unusual case of late dislodgment of a superior vena cava coil.

作者信息

Glotzer Taya V, Shah Monali, Jain Shashank, Zimmerman John M

机构信息

Hackensack University Medical Center, Hackensack, New Jersey.

Rutgers New Jersey Medical School, Newark, New Jersey.

出版信息

HeartRhythm Case Rep. 2018 Jun 11;4(9):405-407. doi: 10.1016/j.hrcr.2018.06.001. eCollection 2018 Sep.

DOI:10.1016/j.hrcr.2018.06.001
PMID:30228965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6140412/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/6140412/5d581937d3d2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/6140412/6797a2853d9d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/6140412/59448d34fe50/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/6140412/5d581937d3d2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/6140412/6797a2853d9d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/6140412/59448d34fe50/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/6140412/5d581937d3d2/gr3.jpg

相似文献

1
Unusual case of late dislodgment of a superior vena cava coil.上腔静脉线圈延迟移位的罕见病例。
HeartRhythm Case Rep. 2018 Jun 11;4(9):405-407. doi: 10.1016/j.hrcr.2018.06.001. eCollection 2018 Sep.
2
Transvenous defibrillator implantation in patients with persistent left superior vena cava and right superior vena cava atresia.经静脉植入除颤器治疗永存左上腔静脉合并右上腔静脉闭锁患者。
Eur Heart J. 1995 May;16(5):704-7. doi: 10.1093/oxfordjournals.eurheartj.a060977.
3
Implantable intravascular defibrillator: defibrillation thresholds of an intravascular cardioverter-defibrillator compared with those of a conventional ICD in humans.可植入血管内除颤器：血管内除颤复律器与传统 ICD 在人体中的除颤阈值比较。
Heart Rhythm. 2014 Feb;11(2):210-5. doi: 10.1016/j.hrthm.2013.10.035. Epub 2013 Oct 18.
4
Optimization of superior vena cava coil position and usage for transvenous defibrillation.经静脉除颤中 superior vena cava 线圈位置及使用的优化 。（注：superior vena cava 一般指上腔静脉，这里可能是特定医学情境下对相关线圈位置及使用的优化研究，因未结合更多背景信息，只能按字面准确翻译专业术语部分）
Heart Rhythm. 2008 Mar;5(3):394-9. doi: 10.1016/j.hrthm.2007.12.001. Epub 2007 Dec 5.
5
Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode.在人体中对单极除颤系统与使用额外上腔静脉电极的除颤系统进行前瞻性随机比较。
Circulation. 1994 Mar;89(3):1090-3. doi: 10.1161/01.cir.89.3.1090.
6
Low defibrillation threshold in a patient with a dual-coil defibrillator lead implanted through a persistent left superior vena cava.一名通过持续左上腔静脉植入双线圈除颤器导线的患者除颤阈值较低。
Pacing Clin Electrophysiol. 2012 Sep;35(9):e274-5. doi: 10.1111/j.1540-8159.2012.03432.x. Epub 2012 May 31.
7
Cable externalization at the proximal portion of the superior vena cava coil in Riata implantable cardioverter defibrillator leads.Riata植入式心脏复律除颤器导线中，上腔静脉线圈近端的导线外置化。
J Cardiol Cases. 2016 Sep 28;15(1):3-5. doi: 10.1016/j.jccase.2016.08.009. eCollection 2017 Jan.
8
Effect of the superior vena cava electrode surface area on defibrillation threshold in different lead systems.上腔静脉电极表面积对不同导联系统除颤阈值的影响。
Pacing Clin Electrophysiol. 1998 Jan;21(1 Pt 1):94-9. doi: 10.1111/j.1540-8159.1998.tb01066.x.
9
Optimization of transvenous coil position for active can defibrillation thresholds.用于主动罐除颤阈值的经静脉线圈位置优化。
J Cardiovasc Electrophysiol. 2000 Jan;11(1):25-9. doi: 10.1111/j.1540-8167.2000.tb00731.x.
10
Novel intravascular defibrillator: defibrillation thresholds of intravascular cardioverter-defibrillator compared to conventional implantable cardioverter-defibrillator in a canine model.新型血管内除颤器：在犬模型中比较血管内除颤器与传统植入式心脏复律除颤器的除颤阈值。
Heart Rhythm. 2011 Feb;8(2):288-92. doi: 10.1016/j.hrthm.2010.10.031. Epub 2010 Oct 27.

本文引用的文献

1
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2017年美国心脏病学会/美国心脏协会/美国心力衰竭学会对2013年美国心脏病学基金会/美国心脏协会心力衰竭管理指南的重点更新：美国心脏病学会/美国心脏协会临床实践指南工作组及美国心力衰竭学会的报告
J Card Fail. 2017 Aug;23(8):628-651. doi: 10.1016/j.cardfail.2017.04.014. Epub 2017 Apr 28.
2
Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention.早期并发症对植入式心脏复律除颤器一级预防患者预后的影响。
Heart Rhythm. 2016 May;13(5):1045-1051. doi: 10.1016/j.hrthm.2015.12.046. Epub 2016 Jan 1.
3
Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).心脏转复除颤器植入术无需诱发心室颤动：一项单盲、非劣效性、随机对照试验（SIMPLE）。
Lancet. 2015 Feb 28;385(9970):785-91. doi: 10.1016/S0140-6736(14)61903-6. Epub 2015 Feb 23.
4
The NO Regular Defibrillation testing In Cardioverter Defibrillator Implantation (NORDIC ICD) trial: concept and design of a randomized, controlled trial of intra-operative defibrillation testing during de novo defibrillator implantation.NO 常规除颤测试在心脏复律除颤器植入术中（NORDIC ICD）试验：一项在新植入除颤器期间进行术中除颤测试的随机对照试验的概念和设计。
Europace. 2015 Jan;17(1):142-7. doi: 10.1093/europace/euu161. Epub 2014 Aug 8.
5
Incidence of lead dislodgement, malfunction and perforation during the first year following device implantation.植入装置后第一年的铅移位、故障和穿孔发生率。
Neth Heart J. 2014 Jun;22(6):286-91. doi: 10.1007/s12471-014-0556-6.
6
Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials.植入式心脏转复除颤器和心脏再同步治疗装置的植入相关并发症：随机临床试验的系统评价。
J Am Coll Cardiol. 2011 Aug 30;58(10):995-1000. doi: 10.1016/j.jacc.2011.06.007.
7
Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database.评估新植入心脏除颤器与早期并发症的关系：安大略省 ICD 数据库的见解。
J Am Coll Cardiol. 2010 Feb 23;55(8):774-82. doi: 10.1016/j.jacc.2009.11.029.
8
Complications associated with defibrillation threshold testing: the Canadian experience.除颤阈值测试相关并发症：加拿大的经验
Heart Rhythm. 2008 Mar;5(3):387-90. doi: 10.1016/j.hrthm.2007.11.018. Epub 2007 Nov 28.
9
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.胺碘酮与索他洛尔对心室除颤阈值的影响：心脏转复除颤器患者的最佳药物治疗（OPTIC）试验
Circulation. 2006 Jul 11;114(2):104-9. doi: 10.1161/CIRCULATIONAHA.106.618421. Epub 2006 Jul 3.
10
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.胺碘酮或植入式心脏复律除颤器用于治疗充血性心力衰竭。
N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.